Price T Rowe Associates Inc Ambrx Biopharma Inc. Put Options Transaction History
Price T Rowe Associates Inc
- $869 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AMAM
# of Institutions
2Shares Held
31.2KCall Options Held
0Put Options Held
0About Ambrx Biopharma Inc.
- Ticker AMAM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,618,400
- Market Cap $1.08B
- Description
- Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate (ADC), which is investigated in various clinical trials for the treatment of breast cancer, gas...